vTv Therapeutics (VTVT)

vTv Therapeutics (VTVT) – FDA

Mar 4, 2024 08:00 AM vTv Therapeutics (VTVT) Announces FDA Submission for First Phase 3 Study of Cadisegliatin
Aug 28, 2023 01:46 PM Cantex Announces Initiation of an Investigator-Initiated Phase 2 Clinical Trial Investigating Azeliragon Combined with Stereotactic Radiosurgery
Jun 16, 2023 08:03 AM
Mar 6, 2023 08:03 AM
Feb 27, 2023 08:03 AM
Jun 4, 2022 01:40 PM
Jan 13, 2022 08:31 AM
Oct 12, 2021 07:30 AM
Sep 23, 2021 04:31 PM
Apr 13, 2021 07:32 AM
Mar 18, 2021 04:08 PM
Dec 16, 2020 06:23 AM
Sep 23, 2020 07:32 AM
Jun 15, 2020 06:58 AM
Feb 10, 2020 07:01 AM
Feb 7, 2020 04:09 PM
Sep 18, 2019 07:32 AM
Sep 11, 2019 07:32 AM
Jul 15, 2019 05:08 PM
Jun 27, 2019 04:53 PM
Jun 6, 2019 08:02 AM
Mar 28, 2019 05:19 PM
Jan 16, 2019 02:05 PM
Oct 24, 2018 09:02 AM
Oct 17, 2018 06:13 AM
Jun 12, 2018 04:32 PM
May 31, 2018 07:41 AM
May 9, 2018 04:45 PM
Apr 9, 2018 04:48 PM
Mar 22, 2018 05:02 PM
Dec 21, 2017 04:34 PM
Nov 8, 2017 05:18 PM
Sep 6, 2017 07:04 AM
Jul 13, 2017 04:32 PM
Jun 1, 2017 07:02 AM
Mar 29, 2017 02:34 PM
Dec 14, 2016 04:32 PM
Nov 23, 2016 11:22 AM
Aug 10, 2016 07:01 AM
Jul 27, 2016 05:23 PM
Jun 14, 2016 07:05 AM
Feb 22, 2016 07:07 AM